Search for: "Doe v. Anderson et al" Results 61 - 80 of 187
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
28 Jun 2016, 6:41 am by Dennis Crouch
Amgen Inc., et al., No. 15-1039 (Does the notice requirement of the BPCIA create an effective six-month exclusivity post-FDA approval?) [read post]
3 Jun 2016, 6:40 am by Dennis Crouch
Amgen Inc., et al., No. 15-1039 (Does the notice requirement of the BPCIA create an effective six-month exclusivity post-FDA approval?) [read post]
18 May 2016, 8:19 am by Dennis Crouch
Amgen Inc., et al., No. 15-1039 (Does the notice requirement of the BPCIA create an effective six-month exclusivity post-FDA approval?) [read post]
3 May 2016, 1:42 am by Dennis Crouch
Amgen Inc., et al., No. 15-1039 (Does the notice requirement of the BPCIA create an effective six-month exclusivity post-FDA approval?) [read post]
18 Apr 2016, 9:58 am by Dennis Crouch
Amgen Inc., et al., No. 15-1039 (Does the notice requirement of the BPCIA create an effective six-month exclusivity post-FDA approval?) [read post]
7 Apr 2016, 2:27 pm by Lawrence B. Ebert
Anderson v.Cryovac, Inc., 862 F.2d 910, 923 (1st Cir. 1988) (emphasisadded); see also Bros Inc. v. [read post]
1 Apr 2016, 8:22 am by Dennis Crouch
Amgen Inc., et al., No. 15-1039 (Does the notice requirement of the BPCIA create an effective six-month exclusivity post-FDA approval?) [read post]
17 Mar 2016, 2:45 am by Dennis Crouch
Amgen Inc., et al., No. 15-1039 (Does the notice requirement of the BPCIA create an effective six-month exclusivity post-FDA approval?) [read post]